Efficacy of Tixagevimab-Cilgavimab as Immunoprophylaxis in Patients With Hematologic Cancer.

ABSTRACT:

SUBMITTER: Salvini M 

PROVIDER: S-EPMC10811587 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature